Multivariate logistic analysis of predictors of response to immunosuppressive therapy in children with aplastic anemia: a double-center study

被引:8
作者
Gu, Changjuan [1 ]
Zhu, Xiaohua [2 ]
Qiao, Xiaohong [1 ]
Zhai, Xiaowen [2 ]
Shi, Wei [1 ]
Xie, Xiaotian [1 ]
机构
[1] Tongji Univ, Tongji Hosp, Dept Paediat, Sch Med, 389 Xincun Rd, Shanghai 200065, Peoples R China
[2] Fudan Univ, Childrens Hosp, Dept Haematol, Shanghai, Peoples R China
关键词
Aplastic anemia; immunosuppressive therapy; antithymocyte globulin; logistic analysis; predictive factor; children; lymphocyte; responsiveness; BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; ANTITHYMOCYTE GLOBULIN; 1ST-LINE TREATMENT; GUIDELINES; MANAGEMENT; DIAGNOSIS; DONOR; CYCLOSPORINE; ALEMTUZUMAB;
D O I
10.1080/16078454.2019.1565149
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Immunosuppressive therapy (IST) composed of antithymocyte globulin (ATG) and cyclosporine A (CSA) is one of the standard therapies in pediatric patients with acquired aplastic anemia (AA), but predictors of IST are lack of consensus. Procedures Ninety-four patients from two pediatric medical centers in China were included between January 2005 and March 2018. Clinical factors associated with the efficacy were analyzed according to multivariate logistic regression model previously established. Results We discovered that overall responsiveness was 77.66%. Five out of 35 factors were statistically significant in univariate analysis. Based on the cutoff point chosen by receiver operating characteristic (ROC) curve, 5 continuous variables were made categorical, among which 3 variables with significance were employed to establish the logistic regression equation. Based on these 3 variables, we found that starting IST within 126 days of the first appearance of symptoms (X1, p = .003), absolute neutrophil count (ANC) higher than 0.435x10(9)/L (X2, p = .012), and rate of decreased actual lymphocyte count (ALC) higher than 59.2% within the 1st week after IST (X3, p = .001) were three independent risk factors for response to IST. The rate of decreased ALC higher than 59.2% after IST was the most significant variable (OR = 9.355, Log (P) = -2.161 + 2.149X1 + 1.662X2 + 2.236X3). The accuracy, sensitivity, and specificity of the model were 86.2%, 94.5% and 57.1%, respectively. Conclusion Duration of AA, ANC and decreased ALC rate after IST might predict the response to IST, among which the rate of decreased ALC after IST is the most important predictive factor.
引用
收藏
页码:282 / 289
页数:8
相关论文
共 31 条
[21]   Survival After Immunosuppressive Therapy in Children with Aplastic Anemia [J].
Nair, Velu ;
Sondhi, Vishal ;
Sharma, Sajay ;
Das, Satyaranjan ;
Sharma, Sanjeevan .
INDIAN PEDIATRICS, 2012, 49 (05) :371-376
[22]   Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia [J].
Scheinberg, Phillip ;
Wu, Colin O. ;
Nunez, Olga ;
Young, Neal S. .
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 144 (02) :206-216
[23]   Association of human leukocyte antigen class II alleles with response to immunosuppressive therapy in Korean aplastic anemia patients [J].
Song, Eun Young ;
Kang, Hyoung Jin ;
Shin, Hee Young ;
Ahn, Hyo Seop ;
Kim, Inho ;
Yoon, Sung-Soo ;
Park, Seonyang ;
Kim, Byoung Kook ;
Park, Myoung Hee .
HUMAN IMMUNOLOGY, 2010, 71 (01) :88-92
[24]   Is the early cyclosporine A level predictive of the outcome of immunosuppressive therapy in severe aplastic anemia? [J].
Song, Moo-Kon ;
Chung, Joo-Seop ;
Joo, Young-Don ;
Kim, Yang-Soo ;
Kim, Sung-Hyun ;
Seol, Young-Mi ;
Shin, Ho-Jin ;
Choi, Young-Jin ;
Cho, Goon-Jae .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 83 (01) :72-78
[25]   A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation [J].
Tichelli, Andre ;
Schrezenmeier, Hubert ;
Socie, Gerard ;
Marsh, Judith ;
Bacigalupo, Andrea ;
Duehrsen, Ulrich ;
Franzke, Anke ;
Hallek, Michael ;
Thiel, Eckhard ;
Wilhelm, Martin ;
Hoechsmann, Britta ;
Barrois, Alain ;
Champion, Kim ;
Passweg, Jakob R. .
BLOOD, 2011, 117 (17) :4434-4441
[26]  
Xie XT, 2015, INT J CLIN EXP MED, V8, P4349
[27]   Comparison of rabbit antithymocyte globulin and Jurkat cell-reactive anti-t lymphocyte globulin as a first-line treatment for children with aplastic anemia [J].
Xie, Xiaotian ;
Shi, Wei ;
Zhou, Xiaoxun ;
Shao, Yuexia ;
Qiao, Xiaohong .
EXPERIMENTAL HEMATOLOGY, 2014, 42 (06) :431-438
[28]   First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy [J].
Yoshida, Nao ;
Kobayashi, Ryoji ;
Yabe, Hiromasa ;
Kosaka, Yoshiyuki ;
Yagasaki, Hiroshi ;
Watanabe, Ken-Ichiro ;
Kudo, Kazuko ;
Morimoto, Akira ;
Ohga, Shouichi ;
Muramatsu, Hideki ;
Takahashi, Yoshiyuki ;
Kato, Koji ;
Suzuki, Ritsuro ;
Ohara, Akira ;
Kojima, Seiji .
HAEMATOLOGICA, 2014, 99 (12) :1784-1791
[29]   Aplastic anemia [J].
Young, Neal S. ;
Scheinberg, Phillip ;
Calado, Rodrigo T. .
CURRENT OPINION IN HEMATOLOGY, 2008, 15 (03) :162-168
[30]   Current concepts in the pathophysiology and treatment of aplastic anemia [J].
Young, Neal S. ;
Calado, Rodrigo T. ;
Scheinberg, Phillip .
BLOOD, 2006, 108 (08) :2509-2519